Product Browser

Last updated: 2022/7/3

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location
Bulk order
Custom Services
2019 Next Day Shipping

COVID-19 Human IgM IgG Rapid Test GMPCoronavirus

  • Catalog # : DC0301
  • Visit Frequency :
  • Countries :
  • Specification
  • Product Description:
  • COVID-19 Human IgM IgG Rapid Test provides a fast, convenient, and qualitative testing of human whole blood, serum and plasma for COVID-19 (SARS-CoV-2) IgM and IgG.
  • Supplied Product:
  • 20 Test Kit:
    Testing Strips (20)

    a. Colloidal Gold-Labeled COVID-19 Nucleocapsid (N) Protein
    b. Colloidal Gold-Labeled COVID-19 Receptor-Binding Domain (RBD) Protein
    c. Colloidal Gold-Labeled Chicken IgY Antibody with less than 0.1% Sodium Azide
    d. Goat Anti-Human IgM Antibody
    e. Goat Anti-Human IgG Antibody
    f. Goat Anti-Chicken IgY Antibody with less than 0.1% Sodium Azide

    Sample Buffers (20)
  • Storage Instruction:
  • Store product at 15-30°C and avoid direct exposure to sunlight.
    Do not open until ready to use.
    Do not freeze or store the product outside the temperature range described above.
    Do not use after the expiration date.
  • Note:
  • Product Image


  • Venous Whole Blood, Serum and Plasma Test Procedure



    Finger Prick Whole Blood Test Procedure


  • Suitable Sample:
  • Human Venous Whole Blood (dipotassium EDTA, sodium heparin, sodium citrate), Serum, Plasma (dipotassium EDTA, sodium heparin, sodium citrate), and Finger Prick Whole Blood (dipotassium EDTA, tripotassium EDTA, no anticogulant)
  • Features:
  • Fast result in 15 minutes
    Easy to operate
    Highly sensitive via visual inspection
  • Intended Use:
  • This product is a lateral flow chromatographic immunoassay for rapid, qualitative detection of human IgM and IgG antibodies against COVID-19 virus in human venous whole blood (dipotassium EDTA, sodium heparin, sodium citrate), serum, plasma (dipotassium EDTA, sodium heparin, sodium citrate), and finger prick whole blood (dipotassium EDTA, tripotassium EDTA, no anticogulant).
  • Regulatory Status:
  • GMP grade
    CE-IVD approved
  • Notification:
  • Clinical laboratories must include this information in their patient test report as specified in FDA guidance:

    This test has not been reviewed by the FDA.
    Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
    Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
    Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
  • Video:

  • Publication Reference
  • Applications
  • Lateral Flow Immunoassay
  • Lateral Flow Immunoassay
  • Result zone of the COVID-19 Testing Strip indicates human IgM line (M line), IgG line (G line) and control line (C line). C line must appear to ensure the quality of sample processing. Please refer to the diagram below for interpretation.
  • Lateral Flow Immunoassay
  • Lateral Flow Immunoassay
  • 31 known COVID-19 positive and 75 known negative EDTA whole blood samples were collected, confirmed with EUA authorized RT-PCR, and tested for COVID-19 IgM and IgG reactivity following symptom onset with results read by two blinded, independent viewers.
  • Application Image
  • RSS
  • YouTube
  • Linkedin
  • Facebook